Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: A Karim, D S Tolbert, T L Hunt, R C Hubbard, K M Harper, G S Geis
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W74152451
